Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT02153502
Depressive Disorder, Depressive Disorder, Treatment-Resistant
Birmingham, Alabama, United States
View Trial Details